RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$783M
AUM Growth
+$86.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$14.5M
2
+$12.9M
3
+$11.6M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$10.1M
5
GKOS icon
Glaukos
GKOS
+$9.98M

Top Sells

1
+$15M
2
+$13.8M
3
+$11.6M
4
NVCR icon
NovoCure
NVCR
+$10.9M
5
BIIB icon
Biogen
BIIB
+$8.3M

Sector Composition

1 Healthcare 89.3%
2 Financials 1.39%
3 Technology 0.15%
4 Energy 0.13%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$5.97M 0.76%
235,000
+97,410
52
$5.88M 0.75%
120,932
+45,932
53
$5.87M 0.75%
480,000
+62,480
54
$5.76M 0.74%
94,320
-52,400
55
$5.73M 0.73%
250,000
-9,556
56
$5.55M 0.71%
50,000
57
$5.51M 0.7%
711,163
+61,163
58
$5.41M 0.69%
70,000
-30,000
59
$5.33M 0.68%
100,000
+64,427
60
$5.03M 0.64%
42,793
-37,397
61
$4.5M 0.57%
236,293
-15,843
62
$4.49M 0.57%
+100,000
63
$4.1M 0.52%
221,914
+46,914
64
$4.08M 0.52%
80,000
-14,231
65
$4M 0.51%
101,950
+84,450
66
$3.98M 0.51%
50,000
-44,707
67
$3.85M 0.49%
+160,000
68
$3.82M 0.49%
850,000
+684,000
69
$3.47M 0.44%
90,000
+15,000
70
$3.12M 0.4%
50,000
71
$2.84M 0.36%
400,000
-25,111
72
$2.7M 0.34%
+100,000
73
$2.4M 0.31%
180,000
+11,128
74
$2.32M 0.3%
40,000
+36,992
75
$2.1M 0.27%
400,000
1 2
3
4 5